MENU
+Compare
NXTC
Stock ticker: NASDAQ
AS OF
Sep 15 closing price
Price
$5.50
Change
+$0.10 (+1.85%)
Capitalization
14.72M

NXTC NextCure Inc Forecast, Technical & Fundamental Analysis

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function... Show more

Industry: #Biotechnology
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NXTC with price predictions
Sep 15, 2025

NXTC in upward trend: price rose above 50-day moving average on September 10, 2025

NXTC moved above its 50-day moving average on September 10, 2025 date and that indicates a change from a downward trend to an upward trend. In of 55 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 10, 2025. You may want to consider a long position or call options on NXTC as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NXTC just turned positive on September 10, 2025. Looking at past instances where NXTC's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for NXTC crossed bullishly above the 50-day moving average on September 15, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where NXTC advanced for three days, in of 225 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NXTC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NXTC broke above its upper Bollinger Band on September 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.465) is normal, around the industry mean (20.594). P/E Ratio (0.000) is within average values for comparable stocks, (53.282). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.156). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (342.112).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NXTC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NXTC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NXTC is expected to report earnings to fall 96.01% to -44 cents per share on October 30

NextCure Inc NXTC Stock Earnings Reports
Q3'25
Est.
$-0.45
Q2'25
Missed
by $10.86
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.08
Q3'24
Missed
by $0.06
The last earnings report on July 31 showed earnings per share of -1128 cents, missing the estimate of -42 cents. With 18.30K shares outstanding, the current market capitalization sits at 14.72M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9000 Virginia Manor Road
Phone
+1 240 399-4900
Employees
82
Web
https://www.nextcure.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TROO1.280.05
+3.64%
TROOPS
NWE56.630.15
+0.27%
NorthWestern Energy Group
MCBS29.060.05
+0.17%
MetroCity Bankshares
EME628.75-0.33
-0.05%
EMCOR Group
LGCL0.13-0.01
-7.05%
Lucas GC Limited

NXTC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NXTC has been loosely correlated with CYTK. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if NXTC jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXTC
1D Price
Change %
NXTC100%
+1.93%
CYTK - NXTC
37%
Loosely correlated
-3.31%
ACET - NXTC
35%
Loosely correlated
-1.07%
ORMP - NXTC
33%
Poorly correlated
-3.73%
GOSS - NXTC
32%
Poorly correlated
-8.09%
DYN - NXTC
29%
Poorly correlated
-2.21%
More